» Articles » PMID: 11072032

Adhesion Molecules Involved in Transendothelial Migration of Human Hematopoietic Progenitor Cells

Overview
Journal Stem Cells
Date 2000 Nov 10
PMID 11072032
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In the process of homing, CD34(+) hematopoietic progenitor cells migrate across the bone marrow endothelium in response to stromal cell-derived factor (SDF)-1. To develop more efficient stem cell transplantation procedures, it is important to define the adhesion molecules involved in the homing process. Here, we identified the adhesion molecules that control the migration of primary human CD34(+) cells across human bone marrow endothelial cells. Migration of CD34(+) cells is enhanced across interleukin 1beta prestimulated bone marrow endothelium, suggesting an important role for the endothelium in adhesion and formation of the chemotactic gradient. Under these conditions, 30-100 ng/ml SDF-1 induced a rapid and efficient migration of CD34(+) cells (+/- 46% migration in 4 h). In contrast, 600-1,000 ng/ml SDF-1 were required for optimal migration across fibronectin-coated filters. Subsequent studies revealed that transendothelial migration of CD34(+) cells is mediated by beta1- and beta2-integrins and PECAM-1 (CD31) but not by CD34 or E-selectin. Whereas these antibodies individually blocked migration for 25%-35%, migration was reduced by 68% when the antibodies were combined. Thus, these adhesion molecules play specific and independent roles in the transmigration process. Finally, O-glycosylated proteins appeared to play a role, since SDF-1-induced migration of CD34(+) cells (treated with a glycoprotease from Pasteurella haemolytica) across endothelial cells was clearly inhibited. In conclusion, we show that efficient SDF-1-induced migration of primary human CD34(+) cells across bone marrow endothelium is mediated by beta1-integrins, beta2-integrins, CD31 and O-glycosylated proteins.

Citing Articles

CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease.

Zhang Z, Gan Q, Han J, Tao Q, Qiu W, Madri J J Cereb Blood Flow Metab. 2023; 43(7):1027-1041.

PMID: 37051650 PMC: 10291450. DOI: 10.1177/0271678X231170041.


Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.

Shahrivari M, Wise E, Resende M, Shuster J, Zhang J, Bolli R Circ Res. 2017; 120(12):1947-1957.

PMID: 28490433 PMC: 5508725. DOI: 10.1161/CIRCRESAHA.116.309947.


Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants.

van der Garde M, van Pel M, Millan Rivero J, De Graaf-Dijkstra A, Slot M, Kleinveld Y Stem Cells Dev. 2015; 24(22):2649-59.

PMID: 26414086 PMC: 4652197. DOI: 10.1089/scd.2015.0138.


No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.

van der Garde M, Brand A, Slot M, De Graaf-Dijkstra A, Zwaginga J, van Hensbergen Y Stem Cells Dev. 2015; 24(12):1448-56.

PMID: 25668618 PMC: 4485368. DOI: 10.1089/scd.2014.0543.


Characteristics of circulating CD31(+) cells from patients with coronary artery disease.

Kim M, Guo L, Kim H, Kim S J Cell Mol Med. 2014; 18(11):2321-30.

PMID: 25267411 PMC: 4224564. DOI: 10.1111/jcmm.12370.